Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice.
Augmentation of the peak bone mass (PBM) may be one of the most effective interventions to reduce the risk of developing osteoporosis later in life; however treatments to augment PBM are currently limited. Our study evaluated whether a greater PBM could be achieved either in the progesterone nuclear...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2010-07-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC2895664?pdf=render |